Correction to: Clinicopathological and prognostic significance of DDX41 mutation in myeloid neoplasms: a systematic review and meta-analysis

Key Points

• DDX41 mutation appears to hold significant prognostic value in myeloid neoplasms, impacting patient outcomes.
• The systematic review synthesizes data from various studies, enhancing understanding of this mutation's role in treatment decisions.
• Analyzing multiple datasets provides stronger evidence for the clinical implications of DDX41 mutations in myeloid cancers.
• These findings may influence future treatment strategies, highlighting the need for biomarker integration in clinical practice.